Literature DB >> 19786375

Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study.

Giovanni Casella1, Renata D'Incà, Lydia Oliva, Marco Daperno, Valeria Saladino, Giorgio Zoli, Vito Annese, Walter Fries, Claudio Cortellezzi.   

Abstract

BACKGROUND: An association has been described in case reports between celiac disease and inflammatory bowel diseases. The aim of the present study is to assess the prevalence of celiac disease in a large series of Italian patients with inflammatory bowel disease.
METHODS: The Italian Group for Inflammatory Bowel Disease conducted a multicentre study between January 2002 and December 2004, in which 22 gastroenterology centres in Italy enrolled 1711 consecutive outpatients with inflammatory bowel disease. 860 (50.2%) had Crohn's disease (415 females, mean age 40, range 18-75), 791 (46.2%) had ulcerative colitis (371 females, mean age 40, range 18-80), and 60 (3.5%) had indeterminate colitis (27 females, mean age 40, range 18-78). All patients underwent serological testing for anti-endomysial antibodies and anti-tissue transglutaminase antibodies; if positive upper GI endoscopy with duodenal biopsy was performed.
RESULTS: Nine of the 1711 patients (0.5%) had serological and histological findings compatible with the diagnosis of celiac disease; six of them had ulcerative colitis and three had Crohn's disease.
CONCLUSIONS: Overall we found a lower risk of celiac disease in our cohort of inflammatory bowel disease patients than in the general population; prevalence of celiac disease was higher in patients with ulcerative colitis than in those with Crohn's disease. 2009 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786375     DOI: 10.1016/j.dld.2009.08.005

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  18 in total

1.  Recurrent duodenal stricture secondary to untreated Crohn's disease.

Authors:  Timothy A Plerhoples; Jeffrey A Norton
Journal:  Dig Dis Sci       Date:  2012-10       Impact factor: 3.199

2.  Gastrointestinal-associated autoantibodies in different autoimmune diseases.

Authors:  Dana Ben-Ami Shor; Hedi Orbach; Mona Boaz; Arie Altman; Juan-Manuel Anaya; Nicola Bizzaro; Angela Tincani; Ricard Cervera; Gerard Espinosa; Ljudmila Stojanovich; Blaž Rozman; Stefano Bombardieri; Salvatore De Vita; Jan Damoiseaux; Danilo Villalta; Elio Tonutti; Renato Tozzoli; Ori Barzilai; Maya Ram; Miri Blank; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Am J Clin Exp Immunol       Date:  2012-05-25

3.  Hypertransaminasemia following withdrawal of thiopurine therapy in an ulcerative colitis patient: mind looking the small bowel!

Authors:  Julio Maria Fonseca Chebli; Maycon Moura Reboredo; Helady Sanders Pinheiro; Bruno do Valle Pinheiro
Journal:  Int J Colorectal Dis       Date:  2015-02-10       Impact factor: 2.571

4.  The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.

Authors:  G Conway; G Velonias; E Andrews; J J Garber; V Yajnik; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2017-01-20       Impact factor: 8.171

5.  Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases.

Authors:  Emily C Oxford; Deanna D Nguyen; Jenny Sauk; Joshua R Korzenik; Vijay Yajnik; Sonia Friedman; Ashwin N Ananthakrishnan
Journal:  Am J Gastroenterol       Date:  2013-02-19       Impact factor: 10.864

Review 6.  Inflammatory bowel disease and celiac disease: overlaps and differences.

Authors:  Virginia Pascual; Romina Dieli-Crimi; Natalia López-Palacios; Andrés Bodas; Luz María Medrano; Concepción Núñez
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

7.  Celiac disease in a child with ulcerative colitis: a possible genetic association.

Authors:  Sam X Cheng; Aileen Raizner; Uma P Phatak; Judy H Cho; Dinesh S Pashankar
Journal:  J Clin Gastroenterol       Date:  2013-02       Impact factor: 3.062

8.  Human leukocyte antigen DQ2/8 prevalence in non-celiac patients with gastrointestinal diseases.

Authors:  Daniel DiGiacomo; Antonella Santonicola; Fabiana Zingone; Edoardo Troncone; Maria Cristina Caria; Patrizia Borgheresi; Gianpaolo Parrilli; Carolina Ciacci
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

9.  First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus.

Authors:  Maryam Alkhatry; Ahmad Al-Rifai; Vito Annese; Filippos Georgopoulos; Ahmad N Jazzar; Ahmed M Khassouan; Zaher Koutoubi; Rahul Nathwani; Mazen S Taha; Jimmy K Limdi
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

10.  A spontaneous mutation of the rat Themis gene leads to impaired function of regulatory T cells linked to inflammatory bowel disease.

Authors:  Marianne Chabod; Christophe Pedros; Lucille Lamouroux; Céline Colacios; Isabelle Bernard; Dominique Lagrange; Daniela Balz-Hara; Jean-Francois Mosnier; Christian Laboisse; Nathalie Vergnolle; Olivier Andreoletti; Marie-Paule Roth; Roland Liblau; Gilbert J Fournié; Abdelhadi Saoudi; Anne S Dejean
Journal:  PLoS Genet       Date:  2012-01-19       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.